PL2638900T3 - Lek do leczenia zmian chorobowych wątroby spowodowanych działaniem czynników chemicznych lub biologicznych - Google Patents

Lek do leczenia zmian chorobowych wątroby spowodowanych działaniem czynników chemicznych lub biologicznych

Info

Publication number
PL2638900T3
PL2638900T3 PL11839641T PL11839641T PL2638900T3 PL 2638900 T3 PL2638900 T3 PL 2638900T3 PL 11839641 T PL11839641 T PL 11839641T PL 11839641 T PL11839641 T PL 11839641T PL 2638900 T3 PL2638900 T3 PL 2638900T3
Authority
PL
Poland
Prior art keywords
drug
chemical
action
biological agents
treating liver
Prior art date
Application number
PL11839641T
Other languages
English (en)
Inventor
Konstantin Andreevich Krasnov
Original Assignee
Tets Viktor Veniaminovich
Tets Georgy Viktorovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tets Viktor Veniaminovich, Tets Georgy Viktorovich filed Critical Tets Viktor Veniaminovich
Publication of PL2638900T3 publication Critical patent/PL2638900T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11839641T 2010-11-08 2011-10-10 Lek do leczenia zmian chorobowych wątroby spowodowanych działaniem czynników chemicznych lub biologicznych PL2638900T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2010145439/15A RU2010145439A (ru) 2010-11-08 2010-11-08 Средство для лечения поражений печени, вызванных воздействием химических или биологических агентов
EP11839641.5A EP2638900B1 (en) 2010-11-08 2011-10-10 Drug for treating liver lesions caused by the action of chemical or biological agents
PCT/RU2011/000792 WO2012064221A1 (ru) 2010-11-08 2011-10-10 Средство для лечения поражений печени, вызванных воздействием химических или биологических агентов

Publications (1)

Publication Number Publication Date
PL2638900T3 true PL2638900T3 (pl) 2019-11-29

Family

ID=46051175

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11839641T PL2638900T3 (pl) 2010-11-08 2011-10-10 Lek do leczenia zmian chorobowych wątroby spowodowanych działaniem czynników chemicznych lub biologicznych

Country Status (6)

Country Link
US (1) US8999959B2 (pl)
EP (1) EP2638900B1 (pl)
ES (1) ES2730943T3 (pl)
PL (1) PL2638900T3 (pl)
RU (1) RU2010145439A (pl)
WO (1) WO2012064221A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2595868C1 (ru) * 2015-03-27 2016-08-27 Виктор Вениаминович Тец Лекарственное средство с гепатопротекторной активностью

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8891898A (en) * 1998-05-26 1999-12-13 Rimma Iliinichna Ashkinazi N-substituted derivatives of 5-oxyiminobarbituric acid
RU2188196C2 (ru) 1998-05-26 2002-08-27 Ашкинази Римма Ильинична N-замещенные производные 5-оксииминобарбитуровой кислоты
CA2414799A1 (en) * 2000-07-05 2002-01-10 Gabor Bernath Inhibitors of copper-containing amine oxidases

Also Published As

Publication number Publication date
ES2730943T3 (es) 2019-11-13
US20130237704A1 (en) 2013-09-12
WO2012064221A1 (ru) 2012-05-18
EP2638900A1 (en) 2013-09-18
US8999959B2 (en) 2015-04-07
EP2638900A4 (en) 2014-04-02
RU2010145439A (ru) 2012-05-20
EP2638900B1 (en) 2019-05-15

Similar Documents

Publication Publication Date Title
HUS2100055I1 (hu) IBAT-inhibitorok májbetegségek kezelésére
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
EP2579936A4 (en) INTRAGASTRIC DEVICE FOR TREATING OBESITY
HRP20160397T1 (hr) Spojevi za liječenje clostridium difficile povezanih bolesti
PT2593423E (pt) Processo para a preparação de agentes de contraste
BR112012022620A2 (pt) "equipamento para tratamento de recipientes de produto quimíco"
PT2460509T (pt) Composição para tratamento de verrugas
PL2598142T3 (pl) Związki eteru difenylowego do zastosowania w leczeniu zaburzeń wątroby
PL2638900T3 (pl) Lek do leczenia zmian chorobowych wątroby spowodowanych działaniem czynników chemicznych lub biologicznych
GB201013060D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009091D0 (en) Compounds for the treatment of clostridium difficile-associated disease
PL2456445T3 (pl) Środek do leczenia chorób skóry
GB201013058D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009108D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009085D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009090D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009094D0 (en) Compounds for the treatment of closridium difficile-associated disease
GB201018173D0 (en) Treatment of chemical/biological warfare agents
GB201015950D0 (en) Treatment of chemical/biological warfare agents
GB201003126D0 (en) Treatment of chemical/biological warfare agents
GB201009097D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201009095D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201012310D0 (en) Composition for the treatment of botulism
HUE051937T2 (hu) IBAT-inhibitorok májbetegségek kezelésére
TWM389118U (en) Biological media- reactor for wastewater treatment